ts emisphere biosciences logo

Investor Relations


Corporate Profile    Stock Quote
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Emisphere Technologies, Inc.'s financial performance into perspective.  
EMIS (Common)
Exchange BB
Price $0.57
Change (%) -0.08 (down12.31%)
Volume 42,500
Data as of Aug 31, 2015 3:52 PM ET
Minimum 20 minute delay
Refresh quote
 
 
Recent Releases
Aug 26, 2015
Emisphere Highlights Eligen Licensee Novo Nordisk's Entry Into Phase 3a Development of Oral Semaglutide, a Once Daily Oral GLP-1

Aug 12, 2015
Emisphere Reports Second Quarter 2015 Financial Results

Aug 6, 2015
Emisphere Announces Second Quarter 2015 Financial Results Conference Call


Copyright © Emisphere, All rights reserved